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ABSTRACT
Astrocytes play a crucial role in neuroinflammation as part of the glia limitans, 
which regulates infiltration of the brain parenchyma by leukocytes. The signaling 
pathways and molecular events, which result from the interaction of activated T 
cells with astrocytes are poorly defined. Here we show that astrocytes promote the 
expression and enzymatic activity of CD39 and CD73 ectonucleotidases in recently 
activated CD4 cells by a contact dependent mechanism that is independent of 
T cell receptor interaction with class II major histocompatibility complex (MHC). 
Transforming growth factor-β (TGF-β) is robustly upregulated and sufficient to 
promote ectonucleotidases expression. T cell adhesion to astrocyte results in 
differentiation to an immunosuppressive phenotype defined by expression of the 
transcription factor Rorγt, which characterizes the CD4 T helper 17 subset. CD39 
activity in T cells in turn inhibits spontaneous calcium oscillations in astrocytes that 
correlated with enhanced and reduced transcription of CCL2 chemokine and Sonic 
hedgehog (Shh), respectively. We hypothesize this TCR-independent interaction 
promote an immunosuppressive program in T cells to control possible brain injury 
by deregulated T cell activation during neuroinflammation. On the other hand, the 
increased secretion of CCL2 with concomitant reduction of Shh might promote 
leukocytes extravasation into the brain parenchyma.
INTRODUCTION
The blood brain barrier (BBB) contributes to the 
immune privilege of the central nervous system (CNS) by 
excluding potentially harmful cells and macromolecules 
from the CNS parenchyma. Immunosurveillance of CNS 
is operated by effector T cells, which migrate across the 
BBB and are retained in cerebrospinal fluid (CSF)- drained 
perivascular and submeningeal spaces. Therein effector T 
cells remain separated from the CNS by glia limitans, a 
functional barrier composed of parenchymal basement 
membrane and astrocyte foot processes, located at 
interfaces between non-neural tissue and CNS parenchyma 
[1, 2]. Encountering of antigen presenting cells and 
effective in situ antigen recognition by the T cell, as 
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observed in experimental autoimmune encephalomyelitis 
(EAE), result in upregulation of proinflammatory 
cytokines, proteases, chemokines, chemokine receptors as 
well as activation markers, breaching of glia limitans and 
neuroinflammation. In contrast, antigen ignorant T cells 
do not upregulate activation markers or pro-inflammatory 
cytokines and do not infiltrate the brain parenchyma [3].
The plasma membrane ecto-5’-nucleotidase CD73, 
an enzyme of the purine catabolic pathway that catalyzes 
the breakdown of AMP to adenosine, is induced in 
activated CD4 cells by TGF-β [4]. Extracellular adenosine 
generated by CD73 enzymatic activity contributes to 
immunosuppression by T regulatory (Treg) cells and might 
play a pivotal role in preventing autoimmune diseases [5, 
6]. The rate-limiting step of the ectonucleotidase cascade 
for adenosine generation is represented by ectonucleoside 
triphosphate diphosphohydrolase 1 (E-NTPDase 1) 
CD39 that hydrolyzes ATP/UTP and ADP/UDP to the 
respective nucleoside (e.g., AMP). T cell receptor (TCR) 
stimulation induces CD39 enzymatic activity in the plasma 
membrane of mouse Treg cells [7], suggesting generation 
of adenosine through CD39 and CD73 is important for 
immunosuppression. On the other hand, adenosine 
generation by CD73 in the CNS is required for efficient 
entry of encephalitogenic lymphocytes into the brain and 
spinal cord during EAE [8]. 
Although serving as a barrier, which restricts the 
entry of inflammatory cells into CNS parenchyma [9-11], 
astrocytes have powerful pro-inflammatory potential. Also, 
dysfunction of astrocytes at the border of inflamed tissue 
leads to spread of neurotoxic inflammation into adjacent 
neural parenchyma. Thus, astrocytes are emerging as 
important regulators of neuroinflammatory events [2]. 
In this paper we show that antigen-independent adhesion 
of recently activated CD4 cells to astrocytes results in 
robust upregulation of plasma membrane CD39 and CD73 
ectonucleotidases as well as T cell polarization to a Th17-
like immunosuppressive phenotype. On the other hand, 
hydrolysis of extracellular ATP by CD39 expressed in T 
cells results in inhibition of ATP-dependent spontaneous 
calcium signaling and transcriptional regulation in 
astrocytes. We propose that this signaling pathway might 
constitute a regulatory mechanism for pro-inflammatory 
activation of antigen-specific T cells in the brain.
RESULTS
Expression of ectonucleotidases CD39 and CD73 
in brain infiltrating CD4 cells in contact with 
astrocytes
Autoantigen specific activation of CD4 cells is used 
to induce EAE in mice. This experimental model fairly 
reproduces neuroinflammation determined by pathogenic 
T cell activation in multiple sclerosis (MS). Confocal 
analysis of brain and spinal cord from EAE mice revealed 
infiltrating CD3+ T cells around blood vessels (Figure 
1A) and in the spinal cord (Figure 1B) that were positive 
for both CD39 and CD73 ectoenzymes in the plasma 
membrane. Interestingly, CD39 or CD73 positive T 
cells were in direct contact with astrocytes as indicated 
by triple labeling for the astrocyte marker glial fibrillary 
acidic protein (GFAP) (arrows in Figure 1A, 1B). Ex vivo 
analysis of brain from mice with EAE in flow cytometry 
confirmed the presence of CD39+CD73+ double positive 
cells within the CD4+ subset and a population of CD39+ 
cells within the CD3+CD4- compartment infiltrating the 
brain that were absent in healthy animals (Figure 1C).
Upregulation of CD39 and CD73 in activated CD4 
cells upon interaction with astrocytes
Since astrocytes are the first neural cells encountered 
by lymphocytes entering the brain, the above observation 
prompted us to investigate whether astrocytes may 
regulate surface expression of CD39 and CD73 in CD4 
cells. Co-cultures of purified murine astrocytes with 
either resting or pre-activated CD4 T cells showed that 
a substantial fraction of activated, but not resting T cells 
adhered to astrocytes after 48 h of culture (Figure 2A). 
FACS analysis after accutase detachment and dissociation 
of adherent cells showed a significantly increased T cell-
to-astrocyte ratio when activated T cells were present 
in the co-culture (Figure 2B). As previously shown [4], 
about 40% of ex vivo isolated naïve CD4 cells were 
CD73+ and did not express CD39 (Supplementary Figure 
S1A). However, CD39 was slightly upregulated upon in 
vitro activation with CD3 and CD28 antibodies (Figure 
2C, left). Notably, the percentage of positive cells as well 
as CD39 and CD73 mean fluorescent intensities (MFIs) 
were significantly and progressively increased in T cells 
that were shifted to co-culture with astrocytes (Figure 
2C, 2D). These results suggest that astrocytes promote 
ectonucleotidase expression in recently activated CD4 
cells.
Upregulation of CD39 and CD73 in activated CD4 
cells adhering to astrocyte is independent of TCR 
interaction with MHC class II
In order to investigate the mechanism through 
which the contact with astrocytes mediated CD39 and 
CD73 upregulation in T cells, we initially focused on 
MHC class II (MHCII) molecules, which are efficiently 
induced in astrocytes by exposure to IFN-γ [12, 13]. 
Indeed, we detected MHCII expression in astrocytes co-
cultured with activated T cells (Figure 3A), in line with 
the observation that a substantial fraction of CD4 cells 
adhering to astrocytes secreted IFN-γ (Supplementary 
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Figure S1B). We addressed whether MHCII in astrocytes 
was responsible for CD39 and CD73 upregulation in T 
cells by co-culturing activated CD4 cells with MHCII 
deficient astrocytes. These cells were equally competent 
to MHCII sufficient cells in inducing CD39 and CD73 in 
T cells, thus indicating that the observed phenotype was 
Figure 1: In vivo adhesion of ectonucleotidase positive T cells to astrocytes. A., B. Representative coronal sections of the brain 
(A) and spinal cord (B) of non-relapsing EAE at 20 days post-immunization. Immunofluorescence staining shows CD3+ (green), CD73+ 
or CD39+ (grey) cells and GFAP+ astrocytes (red). Arrows in A indicate CD73+ and CD39+ CD3+ cells contacting astrocytes at the outer 
perivascular area of blood vessels in stratum subependymal of lateral ventricles. Arrows in B show the same interactions in the spinal 
cord (caudal sections). These results are representative of 3 mice per organ. Scale bar, 50 µm. C. Analysis at FACS of CD39 and CD73 
expression in T cells isolated ex vivo from control and EAE brains.
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Figure 2: Astrocytes promote CD39 and CD73 expression in recently activated CD4 cells. A. Co-cultures of CD4+ T cells 
loaded with calcein-AM (green) with purified astrocytes. Activated T cells massively adhered to astrocytes 48 h after plating, acquiring 
a flat shape (left), while resting (unstimulated) T cells remained suspended over the astrocyte monolayer (right). Scale bar 50 µm. B. 
Statistical analysis of resting vs activated T cells to astrocytes ratio after accutase treatment at 48h of co-culture. Student T test, ***p < 
0.001. C. Representative dot plot of CD39 and CD73 expression in activated CD4+ T cells after 48 h of culture in isolation or adherent 
to astrocytes. D. Fold change in percentage of CD39+73+ T cells adherent to astrocytes, CD73 and CD39 MFIs after 48h (white) and 96h 
(grey) co-culture. Values were normalized to T cells alone (black). One-way ANOVA; Bonferroni’s test for comparison among groups, *p 
< 0.05 ***p < 0.001, ****p < 0.0001; N > 6. 
Figure 3: MHC class II independent astrocyte -T cell interaction. A. MHCII expression on astrocytes alone (black line), 
stimulated with IFN-γ (dotted line) or co-cultured with T cells (shaded) at 48h of co-culture. B. Fold change in percentage of CD39+73+ 
T cells adherent to either wild-type (WT) or MHCII deficient astrocytes. Normalized to T cells alone (black bar). One-way ANOVA; 
Bonferroni’s test for comparison among groups; **p < 0.01, ***p < 0.001; N = 3. C. Fold change in percentage of CD39+73+ cells 
in activated or resting T cells adherent to astrocytes after 48h co-culture. Normalized to T cells alone (black bar). One-way ANOVA; 
Bonferroni’s test for comparison among groups; *p < 0.05, **p < 0.01; N = 3. 
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independent of MHCII mediated interaction (Figure 3B). 
Analysis of resting CD4 T cells co-cultured with astrocytes 
revealed lack of difference in the expression of CD39 
and CD73 compared to T cells cultured alone (Figure 
3C). This observation suggests that only activated T cells 
efficiently upregulate CD39 and CD73 upon interaction 
with astrocytes. Only a slight increase in surface CD39 
and CD73 was detected in astrocytes in response to 
activated CD4 cells (Supplementary Figure S1C).
Adhesion to astrocytes is required for 
upregulation of CD39 and CD73 in T cells
To address whether cell-to-cell contact was required 
for CD39 and CD73 upregulation in T cells, we co-
cultured astrocytes and T cells in a transwell system. 
Physical separation of the two cell types prevented 
CD39 and CD73 induction in T cells (Figure 4A). We 
therefore investigated the possible involvement of T cell/
astrocyte adhesion molecules in regulating CD39 and 
CD73. Upon co-culture with T cells, astrocytes express 
ICAM-1 (CD54) and VCAM-1 (CD105), which are 
ligands for LFA-1 (αLβ2) and VLA-4 (α4β1) integrins, 
respectively [14, 15] (Figure 4B). Pretreatment of T 
cells with α4 blocking antibodies significantly reduced 
T cells adhesion to astrocytes, while blockade of β1 
integrin was ineffective. On the other hand, anti-VCAM-1 
(CD105) antibodies efficiently inhibited T cell adhesion 
to astrocytes and inhibition was further enhanced by 
anti-ICAM-1 (CD54) antibodies (Figure 4C). Antibodies 
addition to cultures did not influence CD4 cell recoveries 
(data not shown). However, in T cells that still adhered to 
astrocytes in the presence of blocking antibodies, CD39 
Figure 4: Integrin mediated astrocyte-T cell adhesion. A. Fold change in percentage of CD39+73+ T cells either adherent to 
astrocytes (white bars) or separated by transwell (transw) (gray bars), CD73 and CD39 MFIs after 48h co-culture. Normalized to T cells 
alone (black bars). One-way ANOVA; Bonferroni’s test for comparison among groups; *p < 0.05; N = 3. B. FACS analysis of VCAM-1 and 
ICAM-1 expression on electronically gated CD11b-CD3- astrocytes either cultured in isolation or co-cultured with T cells for 48h. C. FACS 
analysis of forward scatter (FSC) vs side scatter (SSC) of untreated astrocyte-T cell co-culture or co-culture treated with anti-VCAM-1/
ICAM-1 antibodies. The indicated regions correspond to T cells and astrocytes with percentages of recovered cells. The panel on the right 
shows statistics of T cells/astrocytes ratios in the indicated culture conditions. One-way ANOVA; Bonferroni’s test for comparison among 
groups; *p < 0.05, ****p < 0.0001. D. Fold change in percentage of CD39+73+ cells among CD4 cells adherent to astrocytes without (gray 
bars) or with anti-VICAM-1/ICAM-1 antibodies (black bars) after 48h and 96h culture as compared to T cells cultured in isolation (not 
shown). One-way ANOVA; Bonferroni’s test for comparison among groups; NS = not significant; N = 3. 
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and CD73 were efficiently upregulated (Figure 4D). These 
data suggest that LFA-1 and VLA-4-mediated adhesion as 
well as downstream signaling were not absolutely required 
for plasma membrane ectonucleotidases upregulation in T 
cells, although we cannot exclude that it was impossible to 
achieve complete inhibition of integrin-mediated adhesion 
with antibodies. 
Upregulation of CD39 and CD73 in CD4 cells 
correlates with acquisition of immunosuppressive 
potential
To functionally characterize CD39 and CD73 
expressing T cells generated in co-culture with astrocytes 
we analyzed the transcription of genes coding for master 
regulators of CD4 T cell functional polarization. Real-
time quantitative reverse transcription PCR (qRT-PCR) 
performed in the CD39+73+ subset sorted from cells 
adhering to astrocytes or on total astrocyte-adherent 
cells revealed a marked increase in transcription of Rorc 
(encoding RORγt, the master switch transcription factor 
that defines the Th17 subset) and, to a lesser extent, Foxp3 
(that determines the Treg cells phenotype), whereas 
transcript levels of Tbx21 and Gata-3, which define 
Th1 and Th2 T cells respectively, were not significantly 
different from T cells cultured alone (Figure 5A). We 
did not detect variations in Tbx21, Rorc, Foxp3 or Gata3 
transcripts in CD4 cells separated from astrocytes by 
Figure 5: CD39 and CD73 upregulation correlates with immunosuppressive Th17 phenotype. A. Real-time qRT-PCR 
for Tbx21, Rorc, Foxp3 and Gata3 in CD4+ T cells cultured alone, total T cells adherent to astrocytes (T adher), sorted CD39+73+ T cells 
adherent to astrocytes or T cells separated by transwell after 48 h co-culture. Two-way ANOVA; Bonferroni’s test for comparison with T 
cells cultured alone, ***p < 0.001, ****p < 0.0001; N = 4. B. Expression of RORγt (upper histograms with respective MFI indicated) and 
IL-17A (lower plot) by FACS analysis on CD39+73+ cells sorted as indicated after 96 h co-culture. C. Percentage of UV-labeled proliferating 
cells in suppression assay with CD4+CD39+73+ T cells detached from astrocytes. Graph shows percentage suppression of proliferation by 
T cells cultured in isolation (T alone), CD39+73+ astrocyte-adherent T cells or sorted Treg cells in 72 h culture at different suppressor/
responder cells ratio. One representative experiment with triplicates. Two-way ANOVA; Bonferroni’s test for comparison among groups, 
**p < 0.01,****p < 0.0001, N = 3. 
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transwell chamber with respect to T cells cultured in 
isolation (Figure 5A). These results indicate that the 
observed transcriptional regulation required T cell 
contact with astrocyte. No significant differences in CD4 
cell proliferation were observed in the different culture 
conditions (Supplementary figure S2A, S2B). Flow 
cytometry confirmed that the majority of CD39+73+ T 
cells adhering to astrocytes upregulated RORγt protein 
after 96h of co-culturing (Figure 5B, upper panel). RORγt 
is the master transcriptional regulator of Th17 effector 
functions, however, we detected few cells expressing IL-
17A, the cytokine characterizing this subtype (Figure 5B 
lower panel). The observed phenotype was reminiscent 
of a recently described immunosuppressive Th17 cell 
subset [16]. Moreover, qRT-PCR revealed upregulation 
of both IFNG and IL10 transcripts in CD39+73+ T cells 
adhering to astrocytes (Supplementary Figure S2C). We 
investigated whether CD39+73+ cells were able to suppress 
the proliferation of TCR stimulated T cells in vitro. We 
isolated astrocyte-adherent CD4 cells and further sorted 
CD39+73+ cells at FACS. Co-culture of these cells with 
sorted CD4+CD44-CD62L+CD25- naïve T cells stimulated 
with anti-CD3 antibodies in the presence of irradiated 
splenocytes from cd3e-/- mice, resulted in inhibition of 
T cell proliferation. The efficiency of this inhibition was 
superior to Foxp3 expressing Treg cells isolated from 
Foxp3EGFP transgenic mice (Figure 5C). Indeed, only 
around 50% of ex vivo sorted CD25highFoxp3+ Treg cells 
expressed CD39 and CD73 (Supplementary Figure S3A), 
suggesting that enhanced effect of astrocytes adherent 
cells could be due to selection of ectonuleotidases 
expressing cells. Collectively, these data indicate that 
recently activated CD4 T cells acquire a CD39+73+ Th17 
immunosuppressive phenotype upon interaction with 
astrocytes.
Role of TGF-β in ectonucleotidase upregulation 
in T cells
As previously described [16], treatment with 
exogenous IL-6 and TGF-β induced prominent 
ectonucleotidase upregulation in CD4 cells, mimicking 
the induction triggered by astrocytes (Figure 6A). 
Analysis of IL-6 in the culture supernatant showed 
the progressive increase of the cytokine concentration 
in T cell/astrocyte co-cultures over time, whereas the 
cytokine was barely detectable in cultures of T cells and 
astrocytes grown in isolation (Figure 6B). Analysis of 
IL6 transcripts showed that mRNA levels were increased 
in both T cells and astrocytes in co-culture (Figure 6C). 
Since immunosuppressive Th17 cells are characterized by 
transcriptional upregulation of Stat3 and downregulation 
of the transcription factor Gfi1, we analyzed by real-time 
qRT-PCR Stat3 and Gfi1 genes. Figure 6D shows that, 
analogously to the cell subset described by Chalmin et 
al. [16], CD4 cells adhering to astrocytes significantly 
upregulated Stat3 and downregulated Gfi1, albeit non-
significantly. To explore the possible involvement of 
TGF-β in T cell polarization evoked by interaction with 
astrocytes, we first analyzed TGFB transcript levels 
by real-time qRT-PCR in astrocytes and T cells either 
co-cultured or cultured in isolation. Cell co-culturing 
resulted in higher levels of TGFB1 and TGFB2 transcripts 
in astrocytes and T cells, respectively (Figure 6E). 
Interestingly, incubation of recently activated CD4 cells 
with TGF-β alone was sufficient to promote CD39 and 
CD73 upregulation (Figure 6F), whereas addition of IL-6 
to cultures did not result in CD39 and CD73 variations 
(Figure 6G). Consistently, addition of TGF-β RI kinase 
inhibitor VI significantly inhibited both CD39 and CD73 
expression in adherent CD4 T cells at 48 (left) and 96h 
(right) (Figure 6H). Altogether, these data point to TGF-β 
as the key secreted molecule responsible for astrocyte-
dependent CD39 and CD73 upregulation in the T cell. 
Modulation of spontaneous calcium oscillations in 
astrocytes by CD39 expressed in T cells
It is known that astrocytes communicate among 
themselves and with other brain cells through regulated 
increases in intracellular calcium concentrations [17-20], 
which are sustained by extracellular ATP [reviewed in 
[21]]. Indeed, addition of the ATP hydrolyzing enzyme 
apyrase to astrocyte cultures resulted in significant 
reduction of the percentage of cells showing Ca2+ 
oscillations (Figure 7A, right). Hence, we reasoned that 
ATP hydrolysis by CD39+73+ T cells might negatively 
modulate Ca2+ signaling in astrocytes. Accordingly, 
significantly lower extracellular ATP levels were detected 
in astrocytes co-cultured with T cells compared to 
astrocytes cultured alone (Figure 7B). A two-fold decrease 
in the percentage of astrocytes showing spontaneous 
calcium oscillations was detected in astrocytes co-cultured 
with CD39+73+ T cells (Figure 7C and Supplementary 
Movies S1-2) but not resting CD4 cells (Figure 7D). 
Furthermore, co-culture of activated Entpd1-/- T cells with 
astrocytes resulted in unaltered percentage of astrocytes 
displaying Ca2+ oscillations, indicating that CD39 in 
T cells adhering to astrocytes inhibits purinergic Ca2+ 
signaling in astrocytes (Figure 7E). The lack of effect 
of Entpd1-/- T cells on astrocyte calcium dynamics was 
not due to impaired capacity of T cells to interact with 
astrocytes, as the number of Entpd1-/- T cells adhering 
to astrocytes was comparable to wild-type T cells 
(Supplementary Figure S3B). Finally, we observed 
upregulation of plasma membrane CD73 in Entpd1-/- 
CD4 cells adhering to astrocytes, indicating that CD73 is 
regulated independently of CD39 expression (Figure 7F). 
These results indicate that the reciprocal communication 
between recently activated CD4 cells and astrocytes 
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Figure 6: TGF-β promotes CD39 and CD73 upregulation in T cells. A. FACS analysis for plasma membrane CD39 and CD73 
in naive CD4+ T cells stimulated for 96 h with anti-CD3/CD28 mabs in the presence of TGF-β and IL-6. B. Quantification of IL-6 by 
ELISA in the supernatant of T cells, astrocytes and astrocyte/T cell co-culture. Two-way ANOVA; Bonferroni’s test for comparison among 
groups, **p < 0.01, ****p < 0.0001; N = 3. C. IL6 mRNA levels in purified T cells (left) or astrocytes (right) after 48 h of co-culture. 
Mann-Whitney’s test , **p < 0.01; N = 3. D. Real-time qRT-PCR for Stat3 and Gfi1 in T cells alone and CD39+73+ T cells adherent to 
astrocytes. Mann-Whitney’s test; **p < 0.01; N = 3. E. Expression of TGFB1, TGFB2, TGFB3 assessed by qRT-PCR in T cells (left) (N = 
4) or astrocytes (right) (N = 2) alone or co-cultured for 48 h. Mann-Whitney’s test; *p < 0.05; ***p < 0.01. F.,G. FACS analysis of CD39 
and CD73 expression with MFIs indicated, in CD3/CD28 stimulated CD4 cells (black line), with addition of TGF-β (F) or IL-6 (G) (dashed 
line) for 96 h. H. CD39 and CD73 expression (MFIs) on CD4+ T cells cultured alone (black line) or pre-incubated (filled grey) or not (red) 
with TGF-β RI kinase inhibitor VI before co-culturing with astrocytes for 48 and 96 h. 
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results in a CD39-dependent reduction of ATP-mediated 
Ca2+ activity in astrocytes. Consistent with a functional 
consequence of this signaling circuit in astrocytes, we 
correlated the reduction of spontaneous Ca2+ oscillations 
in astrocytes with a decrease in sonic hedgehog (Shh) 
expression, a secreted molecule that promotes BBB 
integrity [22] and to enhanced transcription of the gene 
encoding the chemokine CCL2, which triggers immune 
cell infiltration [23, 24] (Figure 7G). Therefore, astrocyte 
interaction with activated CD4 cells would implement a 
transcriptional program promoting BBB permeability and 
leukocyte infiltration.
DISCUSSION
The CNS has been considered for long time as 
an immune privileged site. However, the detection of 
activated T cells in the brain parenchyma in healthy 
conditions indicated that these cells could in fact 
cross the BBB. Within this context, astrocytes have 
Figure 7: CD39 mediated inhibition of spontaneous cytosolic Ca2+ oscillations in astrocytes by recently activated CD4 
cells. A. Representative fluorescence images of astrocytes loaded with Oregon green showing spontaneous calcium oscillations (left, 
arrows) and statistical analysis of astrocytes showing calcium oscillations in control culture (astro) or with addition of apyrase. Mann-
Whitney’s test; ****p < 0.0001; N = 3. B. Luciferin/luciferase assay for extracellular ATP concentration in medium from astrocyte or T 
cell cultures, or astrocyte/T cell co-cultures (after 72 h). Means of triplicates ± SEM from a representative experiment are shown. One-
way ANOVA; Bonferroni’s test for comparison among astrocytes cultured alone and astrocytes in co-culture with T cells; *p < 0.05. C. 
Temporal analysis of cytosolic Ca2+ concentration recorded from three representative astrocytes cultured alone (left) or co-cultured with 
activated T cells for 96 h (right) and statistical analysis of astrocytes showing spontaneous calcium oscillations. Mann-Whitney’s test; 
****p < 0.0001, N = 6. D. Same analysis as in C but with resting T cells. Student’s t-test, NS = not significant; N = 2. E. Same analysis 
as in C with activated T cells from wild-type and Entpd1-/- mice. One-way ANOVA; Bonferroni’s test for comparison among groups; *p < 
0.05; **p < 0.01; N = 3. F. FACS analysis of CD39 and CD73 expression in activated Entpd1-/- T cells either cultured alone or adhering to 
astrocytes after 48 h co-culture. G. Real-time qRT-PCR for CCL2, GFAP and Shh in astrocytes either cultured alone or co-cultured with 
activated T cells (at 48 h). Mann-Whitney’s test, **p < 0.01, ****p < 0.0001; N = 4.
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been generally considered to play a beneficial role as 
immunosuppressive and neuroprotective elements. 
Nevertheless, astrocytes were shown to be capable of 
producing a range of proinflammatory cytokines and 
acting as antigen presenting cells (reviewed in ref [25]). A 
number of efforts have been devoted at defining functional 
polarization of CD4 cells upon interaction with astrocytes 
with conflicting results [26-30]. Treg cells were shown to 
develop upon contact with astrocytes and administration 
of these cells alleviated CNS inflammation and clinical 
symptoms in EAE [31]. Yet, the molecular features of 
the immunosuppressive arm eventually triggered by 
astrocytes are so far unknown. In this study we aimed at 
addressing the outcome of the interaction between CD4 
cells and astrocytes in a possible physiological as well 
as pathophysiological context. To this end we analyzed 
in vitro molecular and functional clues resulting from the 
interaction of recently activated CD4 cells with astrocytes. 
This interaction resulted in upregulation of VCAM-1 and 
ICAM-1 in astrocytes, which promoted ectonucleotidase 
expression in T cells. The humanized anti-α4 integrin 
antibody natalizumab has shown therapeutic efficacy in 
relapsing-remitting MS by affecting T cells infiltration 
of the brain [32]. Interestingly, blockade of α4 integrin 
also inhibited T cells adhesion to astrocytes in our assay, 
suggesting that natalizumab might limit astrocyte/T cell 
interaction. We defined the Th17-like immunosuppressive 
phenotype resulting from this interaction that might 
constitute a feed-back mechanism for limiting tissue 
damage by brain infiltrating pro-inflammatory T cells. 
Notably, a population of IL-4 producing CD4 cells was 
recently shown to promote neuroprotection after CNS 
injury in an antigen independent fashion [33]. This study 
together with ours suggest that therapeutic strategies aimed 
at converting brain infiltrating T cells to a neuroprotective 
function can be envisaged.
We have shown that TGF-β is crucially involved 
in astrocyte-dependent CD39 and CD73 upregulation in 
the T cell. These ectonucleotidases contribute to CD4 
cell immunosuppressive function [5-7]. Upregulation of 
TGF-β1 in astrocytes characterizes the early phases of 
MS and EAE, and promotes brain infiltration by myelin 
oligodendrocyte glycoprotein- (MOG-) specific pro-
inflammatory CD4 cells [34]. Interestingly, administration 
of complete Freund adjuvant (CFA), a potent inducer 
of TGF-β1 in astrocytes [34] before induction of EAE 
protects from the disease [35]. These observations 
suggest that TGF-β1 produced by astrocytes might 
also exert a protective role in EAE. The functional 
conversion of activated T cells by TGF-β might represent 
an immunoregulatory mechanism to control tissue 
inflammation in the absence of acute antigen recognition. 
Different signaling mechanisms can skew astrocyte 
function at the BBB resulting in opposite outcomes, such as 
promoting or limiting neuroinflammation [2]. Hydrolysis 
of extracellular ATP by T cell ectonucleotidases may have 
important implications for microvessel permeability, 
independently of adenosine generation, by affecting 
astrocyte Ca2+ activity. Indeed, Ca2+ signaling in astrocyte 
foot processes can influence blood flow through activation 
of phospholipase A2 (PLA2), arachidonic acid (AA) 
mobilization and production of vasoactive AA metabolites 
[36-40], with Ca2+ elevations being more common in 
vasoconstriction [41]. Interestingly, the reduction of 
spontaneous Ca2+ oscillations in astrocytes was associated 
to decrease in Shh expression, a secreted molecule that 
promotes BBB integrity and to enhanced transcription 
of CCL2, which triggers immune cell infiltration. These 
observations suggest that MHC-independent bidirectional 
signaling between astrocytes and T cells may favor T cell 
polarization toward an immunosuppressive phenotype as 
well as promote T cells infiltration into the brain tissue. 
This regulatory path might be important to resolve 
inflammation determined by infectious processes upon 
local clearance and/or limited presentation of pathogenic 
antigen/s. 
In relapsing-remitting MS, episodes of acute 
inflammation, tissue damage and neurological dysfunction 
are followed by deactivation, repair and clinical 
remission [42]. In contrast, the progressive form of the 
disease is characterized by axonal degeneration and 
irreversible disability that are relatively independent from 
inflammation [43]. The oscillatory nature of relapsing-
remitting MS is the result of the local homeostatic 
regulation of T cell activation. The signaling pathways 
leading to this remarkable capacity of suppressing 
inflammation and promoting repair mechanisms in the 
brain could be exploited therapeutically to limit the 
immunopathological damage that can ultimately lead to 
the progressive form of the disease [44]. We hypothesize 
astrocytes-mediated upregulation of CD39 and CD73 in 
activated CD4 cells is part of this adaptive regulatory 
framework at the BBB. The Th17-like immunosuppressive 
activity induced by contact with astrocytes might 
contribute a beneficial immunomodulatory effect during 
neuroinflammation as well as oppose to resolution of 
chronic infections and anti-tumor T cell responses.
MATERIALS AND METHODS
Animals and ethics statement
Mice were bred at Humanitas Research Institute in 
Milan, Italy and Institute for Research in Biomedicine in 
Bellinzona, Switzerland. C57BL/6J (H-2b) and congenic 
FoxP3EGFP (B6.Cg-Foxp3tm2Tch/J) and Cd3e-/- mice were 
from Jackson Lab, Entpd1-/- mice were kindly provided 
by Dr. Simon C. Robson (Beth Israel Deaconess Medical 
Center, Boston, MA). Animals were kept under EU 
directives (2010/63/EU) and the Italian Legislation (L.D. 
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26/2014) for animal research with protocols approved 
by Institute Ethical Committee and the Italian Ministry 
of Health (162/2011-B). In Switzerland, all animal 
experiments were performed in accordance with the Swiss 
Federal Veterinary Office guidelines and authorized by the 
Animal Studies Committee of Cantonal Veterinary.
Cells
CD4+ cells were isolated from the spleen and lymph 
nodes of 2-4 months old female mice using magnetic 
beads coupled to anti-CD4 antibodies (Miltenyi Biotec) 
and sorted by FACS (FACSAria, Beckton Dickinson) as 
CD4+25-62L+44- naive T cells. Alternatively, Foxp3+ Treg 
cells were isolated from Foxp3EGFP mice by sorting for 
CD25 and EGFP. Purified CD4+ cells were stimulated for 
40 h with plate-bound anti-CD3 (10 µg/ml) and anti-CD28 
(5 µg/ml) antibodies (Biolegend) prior to transfer onto 
purified primary astrocyte cell cultures. Astrocytes were 
obtained from neonatal pups (postnatal day 1-3) and pure 
cultures of astrocytes (> 99.5%) were obtained by shaking 
flasks for 24 h at 37 °C at days 2 and 6 after plating. 
Resting or polyclonally activated T cells were plated on 
astrocyte monolayer, at an astrocyte:T cell ratio of 1:0.5 in 
the presence of murine IL-2 (90 U/ml). Co-cultures were 
maintained in RPMI-1640 medium supplemented with 
L-glutamine, non-essential amino acids, sodium pyruvate 
and 5% FBS. In a set of experiments astrocytes were 
treated with IFN-γ (25 ng/ml, Peprotech) for 16 h. CD4 
T cells were differentiated in vitro by IL-6 and TGF-β 
(R&D) as previously described (16). In distinct set of 
experiments, CD4+ cells were plated in transwell culture 
inserts (0.4 µm pore, Costar) or astrocytes were pre-treated 
with anti-ICAM-1 (10 µg/ml) and VCAM-1 (10 µg/ml) 
antibodies for 4 h (Biolegend) to prevent T cells adhesion. 
Alternatively, CD4 cells were incubated with α4 integrin 
blocking antibody (CD49d, R1-2) (50 µg/ml) or with β1 
integrin blocking antibody (CD29, HMβ1-1) (25 µg/ml). 
To block TGF-β receptor, activated CD4 cells were pre-
incubated for 3 h with 10 µM TGF-β RI kinase inhibitor 
VI (SB 431542 hydrate, Sigma Aldrich). 
Antibodies, flow cytometry and ELISA
After 48 h or 96 h of incubation, non-adherent 
CD4 T cells were removed by washing the co-culture 3 
times with PBS (2% FBS). The remaining adherent cells 
(T cells and astrocytes) were incubated with accutase 
(Millipore) at 37°C for 40 min, collected and analyzed 
by flow cytometry. CD4+ cells were stained with the 
following mouse specific monoclonal antibodies: CD3 
(clone 17A2), CD4 (GK1.5), MHCII (M5/114.15.2), 
CD39 (24DMS1), Rorg (gamma, greek letter) t (lower 
case) (AFKJS-9), IFN-γ (XMG1.2), CD25 (PC61 5), 
FoxP3 (FJK-165), CD44 (IM7), CD62L (MEL-14) 
(eBioscience), CD73 (TY11.8) and IL-17A (TC11-
18H10.1) (Biolegend). Astrocytes were stained for CD11b 
(M1/70) (Biolegend), VCAM-1 (429) (BD Bioscience), 
ICAM-1 (YN1/1.7.4) (eBioscience). All samples were 
acquired with a FACSCalibur or FACSCanto (Becton 
Dickinson) and analyzed with FlowJo software (FlowJo 
v10.0.7). IL-6 protein concentration was determined using 
the DuoSet ELISA Development System according to the 
manufacturer’s instructions (R&D Systems). 
Immunosuppression assay
Immunosuppression assay was performed as 
previously described [45]. Briefly 50,000 naïve CD4 
T cells were labeled with Ultraviolet (UV) (Molecular 
Probes) and stimulated with CD3 monoclonal antibody 
(0.5 µg/ml) in the presence of 125,000 irradiated 
splenocytes from cd3e-/- mice. Serial dilutions of Treg 
cells or purified CD39+73+ cells adhering to astrocytes 
were added to cultures. UV dilution in naïve T cells was 
analyzed at 72 h. Acquisitions at FACS were standardized 
by fixed numbers of calibration beads (BD Pharmingen).
Real-time PCR
Quantitative real-time PCR (qRT-PCR) was 
performed as previously described [46]. RNA was isolated 
from cell cultures using the PureZOL RNA Isolation 
Reagent (BioRad), reverse transcribed to cDNA and qRT-
PCR was performed using the Applied Biosystems ViiA™ 
7 RT-PCR System. Experimental cDNA was amplified 
by qRT-PCR where a target cDNA (e.g., Rorc, FoxP3, 
TGFB1) and a reference cDNA (18S, GAPDH and HPRT) 
were amplified simultaneously using an oligonucleotide 
probe with a 5’ fluorescent reporter dye (6-FAM). Data 
were analyzed using the comparative threshold cycle (Ct) 
method and results are expressed as fold difference.
Calcium imaging
Calcium imaging was performed as previously 
described on cells loaded with Oregon Green (Molecular 
Probes) [47]. Briefly, astrocytes were loaded with the 
calcium sensitive dye Oregon Green for 1 h at 37 °C 
in medium and then imaged for calcium activity. The 
recording was performed in KRH (Krebs’-Ringer’s-
HEPES) containing (in µM): 125 NaCl; 5 KCl; 1.2 
MgSO
4
; 1.2 KH2PO4; 25 HEPES; 6 Glucose; 2 CaCl2; 
pH 7,4. Recording chambers were placed on the stage 
of an IX-71 inverted microscope (Olympus) equipped 
with an EMCCD (electron-multiplying CCD) camera 
(Quantem 512x512, Photometrics). Illumination was 
obtained using a light-emitting diode single LED (Cairn 
Research Optoled; 470nm) and a related GFP filter, 16 bit 
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images were captured using a 40X objective [numerical 
aperture (NA): 1.3]. Regions of interest (ROIs) of about 
15-pixel diameter (corresponding to about 12 µm) were 
drawn on the cell cytoplasm of virtually all the cells in the 
recorded field. Time-lapse recording of calcium dynamics 
was obtained with an acquisition rate of 2 Hz for 500 
seconds, and on-line acquisition and off-line analysis were 
performed with MetaFluor software (Molecular Devices). 
Oscillating astrocytes displayed peak ∆F larger than 10 
standard deviations of mean baseline noise. The average 
of F0 was comparable among astrocytes under different 
conditions. Roughly 20-25 astrocytes were analyzed in 
each recording field.
ATP measurment
Cell culture supernatants were measured using a 
luciferin/luciferase assay (Molecular Probes, Leiden, 
NL) according to the manufacturer’s instruction [48]. 
To degrade extracellular ATP in astrocytes cultures, cells 
were incubated for 1 h with the ATP hydrolyzing enzyme 
Apyrase (30U/ml, Sigma Aldrich). 
Non-relapsing rodent EAE
Non-relapsing EAE (nr-EAE) was induced in 
female C57Bl/6 mice by immunization with 200 mg/
mouse of MOG 35-55 (Espikem, Florence, Italy) and 2 
injections of pertussis toxin (500 ng/mouse) the day of 
immunization and 48 h later. Clinical score was assigned 
according to a standard 0 to 5 scale, as described [49]. For 
analysis of brain infiltrating T cells at FACS, mice were 
perfused with HBSS, brains were chopped and digested in 
Collagenase D/DNase I (Roche) for one hour at 37°C with 
shaking. Tissues were resuspended in 35% Percoll and 
then centrifuged 40 min at 400 g to obtain the sediment 
fraction.
Immunostaining and confocal microscopy
Fixed 10 µm-thick frozen brain and spinal cord 
section were immunostained and acquired with an 
Olympus Fluoview FV1000 laser scanning confocal 
microscope in a channel mode with 405, 488, 568, and 647 
nm excitations. Sections were imaged with oil immersion 
lens 40× (NA 1.3) in xy optical sections (1024×1024 
pixels) of 0.3 μm. The z-stacks were reconstructed and 
analyzed by ImageJ Software (1.48v, Java). 
Statistical analysis
Values, expressed as mean ± SEM, were obtained 
from at least 3 independent experiments. Differences 
between multiple groups were analyzed by one-way 
or two-way ANOVA with a Bonferroni’s post hoc test. 
Comparisons between two groups following a normal 
distribution were analyzed using an unpaired t-test (two-
tail distribution) or a Mann-Whitney test as indicated 
in each figure. Statistical analysis was performed using 
GraphPad Prism (Graph-Pad Software). 
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